Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03575897 · ClinicalTrials.gov registry record · NA
Serial Assessment of Body Fat Accrual in Very Preterm Infants
A NA study of Body Weight and Infant, Premature, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03575897: Active NA study of Body Weight and Infant, Premature, sponsored by University of Alabama at Birmingham.
NCT03575897 is a NA study of Body Weight and Infant, Premature that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03575897, a NA study of Body Weight and Infant, Premature, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e. amount of fat mass and fat-free mass) reduces % body fat at 3 months of age.
Primary Outcome
Percent body fat estimated by air displacement plethysmography
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Assessment of infant body composition
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT03575897 still lists
NCT03575897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 282-participant average among 23 other Body Weight trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Body Weight appearing as the primary indexed condition, and to 1 intervention - of which Assessment of infant body composition is the first listed.
NCT03575897 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03575897 about?
NCT03575897 is a clinical study titled "Serial Assessment of Body Fat Accrual in Very Preterm Infants". Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e...
What is the current status of trial NCT03575897?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2018-09-10. Estimated completion is 2026-12.
What conditions does trial NCT03575897 study?
This clinical trial studies the following conditions: Body Weight, Infant, Premature, Adiposity.
What interventions are being tested in trial NCT03575897?
The interventions under investigation include: Assessment of infant body composition (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03575897?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03575897 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Weight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03575897's enrollment target sits among peer trials
50 16th of 23 higher than 8 of 23 other Body Weight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Weight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial
RECRUITING · NA
-
Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans
RECRUITING · NA
-
Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation
RECRUITING · NA
-
Impact of Bright Light Therapy on Prader-Willi Syndrome
RECRUITING · NA
-
Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI